Golimumab, SCH 900259, MK-8259, CNTO-148: A Comparative Review This analysis examines four separate therapies : golimumab, SCH 900259, MK-8259, and CNTO-148. Golimumab, a approved antibody targeting TNF-alpha, https://bookmark-template.com/story28623112/text